STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[8-K] Viatris Inc Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Viatris Inc. furnished an update on its latest results. The company issued a press release reporting financial results for the period ended September 30, 2025, and furnished it under Item 2.02 of an 8‑K. The information is provided as furnished, not filed, and is included as Exhibit 99.1.

The company also announced a conference call and live webcast today at 8:30 a.m. ET to review third-quarter 2025 results. Additional exhibit materials include the cover page Inline XBRL tags (Exhibit 104).

Positive
  • None.
Negative
  • None.
false000179204400017920442025-11-062025-11-06

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_______________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 6, 2025
VIATRIS INC.
(Exact name of registrant as specified in its charter)
Delaware001-3969583-4364296
(State or Other Jurisdiction of Incorporation)(Commission
File Number)
(I.R.S. Employer Identification No.)

1000 Mylan Boulevard, Canonsburg, Pennsylvania, 15317
(Address of Principal Executive Offices)

Registrant's telephone number, including area code: (724) 514-1800

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4 (c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $0.01 per shareVTRSThe NASDAQ Stock Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    




Item 2.02 Results of Operations and Financial Condition.
On November 6, 2025, Viatris Inc. (“Viatris” or the “Company”) issued a press release reporting the Company's financial results for the period ended September 30, 2025. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

The information in this Item 2.02 (including Exhibit 99.1) shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 8.01 Other Events.  

As previously announced, Viatris will host a conference call and live webcast today at 8:30 a.m. ET to review the Company's financial results for the period ended September 30, 2025.



Item 9.01 Financial Statements and Exhibits.
 
(d)Exhibits.
Exhibit No.  Description
99.1
Press release announcing the Company's financial results for the third quarter of 2025, dated November 6, 2025.
104Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.



SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
  VIATRIS INC.
Date: November 6, 2025By:/s/ THEODORA MISTRAS
Theodora Mistras
Chief Financial Officer



FAQ

What did Viatris (VTRS) announce in this 8-K?

The company furnished a press release reporting financial results for the period ended September 30, 2025, included as Exhibit 99.1.

How is the information in Viatris’s 8-K treated under the Exchange Act?

The Item 2.02 information (including Exhibit 99.1) is furnished, not filed, and is not subject to Section 18 liability.

When is Viatris’s Q3 2025 conference call and webcast?

Viatris will host a conference call and live webcast today at 8:30 a.m. ET.

Which exhibits accompany Viatris’s 8-K?

Exhibit 99.1 (press release for Q3 2025 results) and Exhibit 104 (cover page Inline XBRL tags).

What period do the disclosed results cover for Viatris (VTRS)?

The press release reports financial results for the period ended September 30, 2025 (third quarter of 2025).

What is the form type for this Viatris filing?

It is a Form 8-K referencing Items 2.02 and 8.01.
Viatris Inc Ord Shs

NASDAQ:VTRS

VTRS Rankings

VTRS Latest News

VTRS Latest SEC Filings

VTRS Stock Data

11.67B
1.15B
0.28%
85.61%
3.48%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
CANONSBURG